The global radiopharmaceuticals third-party logistics market is experiencing rapid growth as nuclear medicine and targeted radiopharmaceutical therapies become increasingly important in modern healthcare. Radiopharmaceuticals require highly specialized transportation, storage, and distribution because many radioactive isotopes have extremely short half-lives and must reach healthcare facilities within strict delivery timelines. As a result, pharmaceutical companies, biotechnology firms, hospitals, and diagnostic imaging centers are increasingly relying on specialized third-party logistics (3PL) providers to ensure safe, compliant, and timely delivery of these sensitive products.

Growing adoption of molecular imaging, precision oncology, and theranostics is significantly increasing demand for specialized logistics services. Third-party logistics providers are investing in advanced cold chain infrastructure, radiation-safe packaging, real time shipment tracking, regulatory compliance systems, and dedicated transportation networks to support the expanding radiopharmaceutical supply chain. These investments are improving operational efficiency while helping healthcare providers maintain product quality and patient safety.

Market Size and Growth Projections

The global radiopharmaceuticals third-party logistics market was valued at USD 932.0 million in 2025 and is estimated to reach USD 1,073.9 million in 2026. The market is projected to reach approximately USD 2,913.4 million by 2033, expanding at a compound annual growth rate (CAGR) of 15.3% from 2026 to 2033. This strong growth reflects increasing demand for specialized logistics services that support the expanding use of diagnostic and therapeutic radiopharmaceuticals across global healthcare systems.

Several factors continue to support this expansion. The growing incidence of cancer and cardiovascular diseases has increased the use of nuclear imaging and targeted radionuclide therapies. Healthcare providers are adopting more radiopharmaceutical products for personalized medicine, creating greater demand for logistics companies capable of handling radioactive materials safely and efficiently. In addition, pharmaceutical manufacturers are increasingly outsourcing logistics operations to specialized providers in order to improve operational efficiency, reduce costs, and comply with complex international regulations.

Download a free sample copy of the Radiopharmaceuticals Third-party Logistics market report to understand detailed coverage and inclusions in the final report

Key Trends and Market Drivers

One of the most significant market trends is the rapid growth of theranostics, which combines diagnostic imaging with targeted therapy using radiopharmaceuticals. This emerging treatment approach requires highly reliable logistics networks capable of delivering radioactive products within narrow time windows while maintaining product integrity throughout transportation.

Another major driver is the increasing time-sensitive nature of radiopharmaceutical distribution. Many commonly used isotopes have short half-lives, making rapid transportation essential to preserve clinical effectiveness. Specialized third-party logistics providers are expanding same-day delivery capabilities, dedicated air transport services, and temperature-controlled logistics to meet these strict requirements.

Technology is also transforming the market. Companies are implementing real time shipment tracking, GPS monitoring, automated inventory management, cloud based logistics platforms, and digital documentation systems to improve supply chain visibility and regulatory compliance. Advanced packaging technologies, radiation shielding materials, and temperature monitoring devices further enhance transportation safety and product quality.

Stringent regulatory requirements continue to encourage outsourcing to experienced logistics providers. Transporting radioactive medical products requires compliance with nuclear safety regulations, radiation protection standards, customs requirements, and pharmaceutical quality guidelines. Specialized logistics companies possess the expertise and certifications needed to navigate these complex regulatory environments while minimizing delivery delays.

Despite strong growth opportunities, the market also faces several challenges. High transportation costs, limited availability of specialized infrastructure, complex international regulations, and the extremely short shelf life of many radiopharmaceuticals require continuous investment in logistics capabilities. Maintaining uninterrupted cold chain conditions and ensuring rapid customs clearance remain essential for successful product delivery.

Key Market Segments

The radiopharmaceuticals third-party logistics market is segmented by type, service, radioisotope half-life, temperature range, and end use.

• By type, diagnostic radiopharmaceuticals accounted for the largest market share of 0% in 2025. The widespread use of diagnostic imaging procedures such as PET and SPECT scans continues to generate substantial demand for specialized logistics services. Therapeutic radiopharmaceuticals are also expanding rapidly as targeted radionuclide therapies gain wider clinical adoption.
• Based on service, the transportation segment held the largest market share in 2025. Time-critical delivery remains the most important component of radiopharmaceutical logistics because delayed shipments can reduce product effectiveness due to radioactive decay. Logistics providers continue to strengthen dedicated transportation networks to ensure timely delivery.
• By radioisotope half-life, the short half-life segment represented the largest share of the market. Products containing rapidly decaying isotopes require highly coordinated manufacturing, packaging, transportation, and delivery processes to ensure successful clinical use.
• Based on temperature range, the ambient temperature segment accounted for the largest market share in 2025, while specialized cold chain logistics continue to support products requiring controlled temperature conditions.
• By end use, pharmaceutical and biopharmaceutical companies represented the largest customer segment due to increasing production of radiopharmaceutical products and greater reliance on outsourced logistics providers for global distribution.

Looking for more specific insights? Customize this report to suite your business needs

Regional Market Performance

North America dominated the global radiopharmaceuticals third-party logistics market with a 38.1% revenue share in 2025. The region benefits from advanced nuclear medicine infrastructure, increasing adoption of theranostics, strong pharmaceutical manufacturing capabilities, and well-established regulatory frameworks. The United States remains the largest individual market due to high demand for diagnostic imaging and targeted cancer therapies.

Europe represents another important regional market supported by expanding nuclear medicine programs, increasing healthcare investments, and strict regulatory standards for radioactive material transportation. Countries including Germany, France, the United Kingdom, Italy, and the Netherlands continue to strengthen radiopharmaceutical supply chains.

Asia Pacific is expected to register the fastest growth during the forecast period. Expanding healthcare infrastructure, rising cancer prevalence, increasing investments in nuclear medicine, and growing pharmaceutical manufacturing activities are driving demand for specialized logistics services across China, India, Japan, South Korea, and Australia.

Latin America and the Middle East & Africa are also witnessing gradual market expansion as healthcare systems improve access to advanced diagnostic imaging and radiopharmaceutical therapies while strengthening regulatory frameworks for radioactive material transportation.

Top Industry Players

The radiopharmaceuticals third-party logistics market is highly specialized, with companies focusing on regulatory compliance, rapid transportation, radiation safety, and temperature-controlled distribution. Leading providers continue to invest in advanced logistics infrastructure, digital tracking technologies, dedicated transportation fleets, and strategic partnerships with pharmaceutical manufacturers and healthcare providers.

Major industry participants include:

• Courier Health
• United Parcel Service Inc. (UPS)
• World Courier
• AirNet II
• GTA Air
• Carrier Labs
• Kalitta Charters
• NAF
• PHSE

Explore our dedicated business services:

• US. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.